{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T01:57:25Z","timestamp":1768787845600,"version":"3.49.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,17]],"date-time":"2024-12-17T00:00:00Z","timestamp":1734393600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002947","name":"Anhui Medical University","doi-asserted-by":"publisher","award":["2022xkj100"],"award-info":[{"award-number":["2022xkj100"]}],"id":[{"id":"10.13039\/501100002947","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81603361"],"award-info":[{"award-number":["81603361"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Therapeutic Research"],"published-print":{"date-parts":[[2025]]},"DOI":"10.1016\/j.curtheres.2024.100771","type":"journal-article","created":{"date-parts":[[2024,12,26]],"date-time":"2024-12-26T18:51:55Z","timestamp":1735239115000},"page":"100771","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["A Clinical Nomogram for Predicting Substandard Serum Valproic Acid Concentrations in Chinese Patients With Epilepsy"],"prefix":"10.1016","volume":"102","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1527-6483","authenticated-orcid":false,"given":"Zi-Hao","family":"Duan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3702-7907","authenticated-orcid":false,"given":"Chun-Yuan","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun-Jie","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7476-309X","authenticated-orcid":false,"given":"Zhi-Xiang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-1342-8923","authenticated-orcid":false,"given":"Jing","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1433-8972","authenticated-orcid":false,"given":"Fa-Cai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.curtheres.2024.100771_bib0001","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1111\/j.1528-1167.2008.01561.x","article-title":"Antiepileptic drugs-best practice guidelines for therapeutic drug monitoring: a position paper by the subcommission on therapeutic drug monitoring, ILAE Commission on Therapeutic Strategies","volume":"49","author":"Patsalos","year":"2008","journal-title":"Epilepsia"},{"key":"10.1016\/j.curtheres.2024.100771_bib0002","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1038\/clpt.1985.116","article-title":"Valproic acid clearance: unbound fraction and diurnal variation in young and elderly adults","volume":"37","author":"Bauer","year":"1985","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.curtheres.2024.100771_bib0003","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/00007691-199202000-00009","article-title":"Binding parameters of valproic acid to serum protein in healthy adults at steady state","volume":"14","author":"Kodama","year":"1992","journal-title":"Ther Drug Monit"},{"issue":"8","key":"10.1016\/j.curtheres.2024.100771_bib0004","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1002\/phar.1965","article-title":"Clinical importance of monitoring unbound valproic acid concentration in patients with hypoalbuminemia","volume":"37","author":"Dor\u00e9","year":"2017","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.curtheres.2024.100771_bib0005","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1002\/bdd.636","article-title":"Population pharmacokinetics of valproate in Mexican children with epilepsy","volume":"29","author":"Correaa","year":"2008","journal-title":"Biopharm Drug Dispos"},{"key":"10.1016\/j.curtheres.2024.100771_bib0006","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1002\/j.1552-4604.1997.tb04301.x","article-title":"Population-based investigation of valproic acid relative clearance using nonlinear mixed effects modeling: influence of drug-drug interaction and patient characteristics","volume":"37","author":"Yukawa","year":"1997","journal-title":"Clin Pharmacol"},{"key":"10.1016\/j.curtheres.2024.100771_bib0007","doi-asserted-by":"crossref","DOI":"10.12659\/MSM.934275","article-title":"Factors influencing sodium valproate serum concentrations in patients with epilepsy based on logistic regression analysis","volume":"27","author":"Lan","year":"2021","journal-title":"Med Sci Monit"},{"issue":"1\u20132","key":"10.1016\/j.curtheres.2024.100771_bib0008","first-page":"9","article-title":"Consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology: update 2017","volume":"51","author":"Hiemke","year":"2018","journal-title":"Pharmacopsychiatry"},{"issue":"6","key":"10.1016\/j.curtheres.2024.100771_bib0009","first-page":"165","article-title":"Observing and analyzing the relationship between plasma concentration of sodium valproate and antiepileptic efficacy together with adverse reactions","volume":"7","author":"Li","year":"2020","journal-title":"EClinicalMedicine"},{"issue":"6","key":"10.1016\/j.curtheres.2024.100771_bib0010","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1007\/s13318-017-0413-2","article-title":"Observation of clinically relevant drug interaction in chimeric mice with humanized livers: the case of valproic acid and carbapenem antibiotics","volume":"42","author":"Suzuki","year":"2017","journal-title":"Eur J Drug Metab Pharmacokinet"},{"issue":"3","key":"10.1016\/j.curtheres.2024.100771_bib0011","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.kjms.2016.12.001","article-title":"Drug interaction between valproic acid and carbapenems in patients with epileptic seizures","volume":"33","author":"Huang","year":"2017","journal-title":"Kaohsiung J Med Sci"},{"issue":"2","key":"10.1016\/j.curtheres.2024.100771_bib0012","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.braindev.2017.09.004","article-title":"Correlation between UGT2B7\u00d72 gene polymorphisms and plasma concentrations of carbamazepine and valproic acid in epilepsy patients","volume":"40","author":"Zhang","year":"2018","journal-title":"Brain Dev"},{"issue":"1","key":"10.1016\/j.curtheres.2024.100771_bib0013","article-title":"Determination of unbound valproic acid in plasma using centrifugal ultrafiltration and gas chromatography: application in TDM","volume":"588","author":"Gu","year":"2020","journal-title":"Anal Biochem"},{"issue":"1","key":"10.1016\/j.curtheres.2024.100771_bib0014","first-page":"58","article-title":"Analysis of dangerous factors for spontaneous brainstem hemorrhage","volume":"23","author":"Wang","year":"2003","journal-title":"Suzhou Univers J Med Sci"},{"key":"10.1016\/j.curtheres.2024.100771_bib0015","first-page":"2690","article-title":"Protective effect of human umbilical cord mesenchymal stem cells on acute drug-induced liver injury after conditioning in haploidentical hematopoietic stem cell transplantation","volume":"23","author":"Wang","year":"2019","journal-title":"Chin J Tissue Eng Res"},{"key":"10.1016\/j.curtheres.2024.100771_bib0016","first-page":"631","article-title":"Clinical and pathological features of patients with multiple myeloma complicated with renal impairment","volume":"54","author":"Wang","year":"2019","journal-title":"J Zhengzhou Univ (Med Sci)"},{"key":"10.1016\/j.curtheres.2024.100771_bib0017","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/cac2.12067","article-title":"A nomogram for predicting overall survival in patients with low-grade endometrial stromal sarcoma: a population-based analysis","volume":"40","author":"Wu","year":"2020","journal-title":"Cancer Commun"},{"key":"10.1016\/j.curtheres.2024.100771_bib0018","first-page":"2213","article-title":"A retrospective study on factors of standard-reaching rate of valproic acid serum concentration in inpatients","volume":"38","author":"Pan","year":"2018","journal-title":"Chin Hosp Pharm J"},{"key":"10.1016\/j.curtheres.2024.100771_bib0019","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1515\/CCLM.2002.172","article-title":"Clinical utility of free drug monitoring","volume":"40","author":"Dasgupta","year":"2002","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.curtheres.2024.100771_bib0020","first-page":"1","article-title":"Clinical significance of drug binding, protein binding, and binding displacement drug interactions","volume":"36","author":"DeVane","year":"2002","journal-title":"Psychopharmacol Bull"},{"key":"10.1016\/j.curtheres.2024.100771_bib0021","doi-asserted-by":"crossref","first-page":"121","DOI":"10.2146\/ajhp140191","article-title":"Comparison of free fraction serum valproic acid concentrations between inpatients and outpatients","volume":"72","author":"Gibbs","year":"2015","journal-title":"Am J Health-Syst Pharm"},{"key":"10.1016\/j.curtheres.2024.100771_bib0022","series-title":"Clinical Challenges in Therapeutic Drug Monitoring. Special Populations, Physiological Conditions and Pharmacogenomics. Amsterdam: Elsevier","first-page":"71","article-title":"Chapter 4\u2014Monitoring free drug concentration: clinical usefulness and analytical challenges","author":"Dasgupta","year":"2016"},{"issue":"1","key":"10.1016\/j.curtheres.2024.100771_bib0023","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s40560-022-00620-9","article-title":"Worsening or improving hypoalbuminemia during continuous renal replacement therapy is predictive of patient outcome: a single-center retrospective study","volume":"10","author":"Rhee","year":"2022","journal-title":"J Intensive Care"},{"key":"10.1016\/j.curtheres.2024.100771_bib0024","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0238201","article-title":"Safety range of free valproic acid serum concentration in adult patients","volume":"15","author":"Tseng","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.curtheres.2024.100771_bib0025","doi-asserted-by":"crossref","first-page":"958","DOI":"10.3109\/00498254.2011.596582","article-title":"Inhibition mechanism of carbapenem antibiotics on acylpeptide hydrolase, a key enzyme in the interaction with valproic acid","volume":"41","author":"Suzuki","year":"2011","journal-title":"Xenobiotica"},{"key":"10.1016\/j.curtheres.2024.100771_bib0026","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1345\/aph.1M296","article-title":"The effect of carbapenem antibiotics on plasma concentrations of valproic acid","volume":"43","author":"Mancl","year":"2009","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.curtheres.2024.100771_bib0027","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0378-5173(01)00916-4","article-title":"Carbapenem antibiotics inhibit valproic acid transport in Caco-2 cell monolayers","volume":"233","author":"Torii","year":"2002","journal-title":"Int J Pharm"},{"key":"10.1016\/j.curtheres.2024.100771_bib0028","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1124\/dmd.110.034231","article-title":"Characterization of inhibitory effect of carbapenem antibiotics on the deconjugation of valproic acid glucuronide","volume":"38","author":"Masuo","year":"2010","journal-title":"Drug Metab Dispos"},{"issue":"5","key":"10.1016\/j.curtheres.2024.100771_bib0029","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1097\/FTD.0000000000000316","article-title":"The effect of different carbapenem antibiotics (ertapenem, imipenem\/cilastatin and meropenem) on serum valproic acid concentrations","volume":"38","author":"Wu","year":"2016","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.curtheres.2024.100771_bib0030","doi-asserted-by":"crossref","first-page":"126","DOI":"10.3109\/00498254.2015.1054002","article-title":"In vivo inhibition of acylpeptide hydrolase by carbapenem antibiotics causes the decrease of plasma concentration of valproic acid in dogs","volume":"46","author":"Suzuki","year":"2016","journal-title":"Xenobiotica"},{"key":"10.1016\/j.curtheres.2024.100771_bib0031","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1080\/03602530701690341","article-title":"Interaction between valproic acid and carbapenem antibiotics","volume":"39","author":"Mori","year":"2007","journal-title":"Drug Metab Rev"},{"issue":"1","key":"10.1016\/j.curtheres.2024.100771_bib0032","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/imj.14693","article-title":"Higher rates of carbapenem-related seizures in older hospitalised adults","volume":"50","author":"Han-Yee","year":"2020","journal-title":"Intern Med J"},{"key":"10.1016\/j.curtheres.2024.100771_bib0033","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1111\/jcpt.12705","article-title":"Intentional use of carbapenem antibiotics for valproic acid toxicity: a case report","volume":"43","author":"Khobrani","year":"2018","journal-title":"J Clin Pharm Ther"},{"key":"10.1016\/j.curtheres.2024.100771_bib0034","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1248\/bpb1978.12.255","article-title":"Effects of anticonvulsants on plasma levels and entero-hepatic circulation of valproic acid and on hepatic drug metabolizing enzyme activities in rats","volume":"12","author":"Ogiso","year":"1989","journal-title":"J Pharmacobiodyn"},{"key":"10.1016\/j.curtheres.2024.100771_bib0035","first-page":"155","article-title":"Species differences in phenobarbital-mediated UGT gene induction in rat and human liver microtissues","volume":"29","author":"Simon","year":"2020","journal-title":"Toxicol Rep"},{"key":"10.1016\/j.curtheres.2024.100771_bib0036","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1097\/FPC.0b013e32835ea0b2","article-title":"Valproic acid pathway: pharmacokinetics and pharmacodynamics","volume":"23","author":"Ghodke-Puranik","year":"2013","journal-title":"Pharmacogenet Genomics"},{"key":"10.1016\/j.curtheres.2024.100771_bib0037","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/bdd.2510140108","article-title":"Pharmacokinetic interaction between valproic acid and phenobarbital","volume":"14","author":"Pokrajac","year":"1993","journal-title":"Biopharm Drug Dispos"},{"key":"10.1016\/j.curtheres.2024.100771_bib0038","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2020.106939","article-title":"Pharmacodynamic interactions of antiepileptic drugs: from bench to clinical practice","volume":"104","author":"Verrotti","year":"2020","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.curtheres.2024.100771_bib0039","first-page":"417","article-title":"CYP2C9\u00d73\/*3 gene expression affects the total and free concentrations of valproic acid in pediatric patients with epilepsy","volume":"9","author":"Wu","year":"2021","journal-title":"Pharmacogenomics Pers Med"}],"container-title":["Current Therapeutic Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0011393X24000419?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0011393X24000419?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T22:28:24Z","timestamp":1762122504000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0011393X24000419"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":39,"alternative-id":["S0011393X24000419"],"URL":"https:\/\/doi.org\/10.1016\/j.curtheres.2024.100771","relation":{},"ISSN":["0011-393X"],"issn-type":[{"value":"0011-393X","type":"print"}],"subject":[],"published":{"date-parts":[[2025]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Clinical Nomogram for Predicting Substandard Serum Valproic Acid Concentrations in Chinese Patients With Epilepsy","name":"articletitle","label":"Article Title"},{"value":"Current Therapeutic Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.curtheres.2024.100771","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100771"}}